{"brief_title": "Study to Assess Efficacy of Tacrolimus + Methotrexate Versus Placebo + Methotrexate in Treatment of Rheumatoid Arthritis", "brief_summary": "The purpose of this study is to evaluate the efficacy of the combination of tacrolimus + methotrexate compared to methotrexate alone in the treatment of the signs and symptoms of rheumatoid arthritis over 6 months in patients with partial response to methotrexate.", "detailed_description": "This is a Phase III, 6 month randomized, double-blind, placebo controlled multi-center study with a 6 month open-label extension. Patients will be randomized to the tacrolimus + methotrexate arm or the placebo + methotrexate arm in a ratio of 2:1. Patients who complete the 6-month double-blind phase will be eligible to enroll in the open-label phase of the study.", "condition": ["Rheumatoid Arthritis"], "intervention_type": ["Drug", "Drug"], "intervention_name": ["Tacrolimus (Prograf\u00ae)", "Methotrexate"], "criteria": "Inclusion Criteria - Willing to discontinue DMARDs, other than methotrexate - Has a diagnosis of Rheumatoid Arthritis using American College of Rheumatology Criteria, of at least 6 months duration - Have been receiving oral or parenteral methotrexate for at least 3 months Exclusion Criteria - Has received tacrolimus for any indication - Has moderate or severe liver disease - Has a known history of HIV infection - Has serum creatinine outside the normal range", "gender": "All", "minimum_age": "18 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "keyword": "Tacrolimus, Prograf\u00ae, FK506", "mesh_term": ["Arthritis", "Arthritis, Rheumatoid", "Methotrexate", "Tacrolimus"], "id": "NCT00036153"}